{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Generalised pustular psoriasis",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_acitretin",
          "name": "Acitretin"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_infliximab",
          "name": "Infliximab"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_secukinumab",
          "name": "Secukinumab"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_etanercept",
          "name": "Etanercept"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_ixekizumab",
          "name": "Ixekizumab"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_brodalumab",
          "name": "Brodalumab"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_neratinib",
          "name": "Neratinib"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_apremilast",
          "name": "Apremilast"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_tazarotene",
          "name": "Tazarotene"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 3
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_acitretin",
          "type": "Drug",
          "label": "Acitretin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_secukinumab",
          "type": "Drug",
          "label": "Secukinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ixekizumab",
          "type": "Drug",
          "label": "Ixekizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_brodalumab",
          "type": "Drug",
          "label": "Brodalumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_neratinib",
          "type": "Drug",
          "label": "Neratinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_apremilast",
          "type": "Drug",
          "label": "Apremilast",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tazarotene",
          "type": "Drug",
          "label": "Tazarotene",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_gp_psoriasis",
          "type": "Disease",
          "label": "Generalised Pustular Psoriasis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target_th17",
          "type": "Target",
          "label": "Th17 cells",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target_il17",
          "type": "Target",
          "label": "IL-17",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target_tnf",
          "type": "Target",
          "label": "TNF",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway_inflammation",
          "type": "Pathway",
          "label": "Inflammatory Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway_immune_response",
          "type": "Pathway",
          "label": "Immune Response Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph1",
          "type": "Phenotype",
          "label": "Skin Inflammation",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph2",
          "type": "Phenotype",
          "label": "Pustular Lesions",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_acitretin",
          "target": "n_target_th17",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知作用机制"
        },
        {
          "source": "drug_corticosteroids",
          "target": "n_target_tnf",
          "relation": "inhibits",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "常用于抑制炎症"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_pathway_inflammation",
          "relation": "modulates",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "影响免疫通路"
        },
        {
          "source": "drug_infliximab",
          "target": "n_target_tnf",
          "relation": "inhibits",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "抗TNF机制"
        },
        {
          "source": "drug_adalimumab",
          "target": "n_target_tnf",
          "relation": "inhibits",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "抗TNF机制"
        },
        {
          "source": "drug_secukinumab",
          "target": "n_target_il17",
          "relation": "inhibits",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "抑制IL-17"
        },
        {
          "source": "drug_etanercept",
          "target": "n_target_tnf",
          "relation": "inhibits",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "抗TNF机制"
        },
        {
          "source": "drug_ixekizumab",
          "target": "n_target_il17",
          "relation": "inhibits",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "抑制IL-17"
        },
        {
          "source": "drug_brodalumab",
          "target": "n_target_il17",
          "relation": "inhibits",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "抑制IL-17"
        },
        {
          "source": "drug_neratinib",
          "target": "n_pathway_inflammation",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "假设影响炎症"
        },
        {
          "source": "drug_apremilast",
          "target": "n_pathway_immune_response",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "影响免疫通路"
        },
        {
          "source": "drug_tazarotene",
          "target": "n_ph1",
          "relation": "acts_on",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "已知治疗效果"
        },
        {
          "source": "n_target_th17",
          "target": "n_pathway_inflammation",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "通路联系"
        },
        {
          "source": "n_target_il17",
          "target": "n_pathway_immune_response",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "通路联系"
        },
        {
          "source": "n_target_tnf",
          "target": "n_pathway_inflammation",
          "relation": "involved_in",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "通路联系"
        },
        {
          "source": "n_pathway_inflammation",
          "target": "n_ph1",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与皮肤炎症相关"
        },
        {
          "source": "n_pathway_inflammation",
          "target": "n_ph2",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "与脓疱损伤相关"
        },
        {
          "source": "n_pathway_immune_response",
          "target": "n_ph1",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "免疫通路相关结局"
        },
        {
          "source": "n_pathway_immune_response",
          "target": "n_ph2",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "免疫通路相关结局"
        },
        {
          "source": "drug_acitretin",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_corticosteroids",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_infliximab",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_adalimumab",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_secukinumab",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_etanercept",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_ixekizumab",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_brodalumab",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_neratinib",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_apremilast",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        },
        {
          "source": "drug_tazarotene",
          "target": "n_gp_psoriasis",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "直接支持假设"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种药物通过不同机制支持治疗广义脓疱型银屑病的假设",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "药物能有效到达靶部位（常识判断）"
    ],
    "uncertainties": [
      "不同药物的长期效果与个体差异仍需进一步研究"
    ],
    "next_focus_for_pi": [
      "是否需要进一步探讨与新靶点的潜在联系？"
    ]
  }
}